The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Innate Pharma (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Phase I experience with rogaratinib in patients (pts) with urothelial carcinoma (UC) selected based on FGFR mRNA overexpression.
 
Emmanuelle Kempf
Travel, Accommodations, Expenses - Bayer
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Christophe Tournigand
Honoraria - Bayer; Bristol-Myers Squibb; MSD; Roche; Sanofi
Consulting or Advisory Role - Bayer
Research Funding - Roche
Travel, Accommodations, Expenses - Bayer; MSD; Roche
 
Pablo Gajate
Consulting or Advisory Role - Ipsen
Speakers' Bureau - IPSEN; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Daniel Shao-Weng Tan
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Loxo; Merck; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche
 
Philippe Cassier
No Relationships to Disclose
 
Lucia Nogova
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Novartis; Pfizer
 
Richard Cathomas
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology; Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Martin Schostak
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD; Novartis; Roche
 
Andreas Janitzky
Consulting or Advisory Role - Eisai; EUSA Pharma; Janssen; Roche
Travel, Accommodations, Expenses - Janssen; MSD; Roche
 
Martin Wermke
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Kite, a Gilead company; Merck; Novartis; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Heidelberg Pharma; Kite, a Gilead company; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Glenmark
 
Cyrus Sayehli
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Alejandro Navarro
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
Expert Testimony - Oryzon Genomics
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer
 
Se Hoon Park
Honoraria - Merck Sharp & Dohme; Sanofi/Aventis
Consulting or Advisory Role - Janssen Oncology; Lilly
Research Funding - Kura Oncology; Ono Pharmaceutical
 
Ana-Maria Piciu
Employment - Bayer; Chrestos
Consulting or Advisory Role - Chrestos
Travel, Accommodations, Expenses - Chrestos
 
Sebastian Bender
Employment - Bayer
 
Hendrik Nogai
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Peter Ellinghaus
Employment - Bayer
 
Markus Joerger
No Relationships to Disclose
 
Martin H. Schuler
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)